Thakker Geeta D, Frangogiannis Nikolaos G, Bujak Marcin, Zymek Paul, Gaubatz John W, Reddy Anilkumar K, Taffet George, Michael Lloyd H, Entman Mark L, Ballantyne Christie M
Dept. of Medicine, Baylor College of Medicine, 6565 Fannin, M.S. A-601, Houston, TX 77030, USA.
Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2504-14. doi: 10.1152/ajpheart.00322.2006. Epub 2006 May 26.
Epidemiological studies indicate that obesity, insulin resistance, and diabetes are important comorbidities of patients with ischemic heart disease and increase mortality and development of congestive heart failure after myocardial infarction. Although ob/ob and db/db mice are commonly used to study obesity with insulin resistance or diabetes, mutations in the leptin gene or its receptor are rarely the cause of obesity in humans, which is, instead, primarily a consequence of dietary and lifestyle factors. Therefore, we used a murine model of diet-induced obesity to examine the physiological effects of obesity and the inflammatory and healing response of diet-induced obese (DIO) mice after myocardial ischemia-reperfusion injury. DIO mice developed hyperinsulinemia and insulin resistance and hepatic steatosis, with significant ectopic lipid deposition in the heart and cardiac hypertrophy in the absence of significant changes in blood pressure. The mRNA levels of chemokines at 24 h and cytokines at 24 and 72 h of reperfusion were higher in DIO than in lean mice. In granulation tissue at 72 h of reperfusion, macrophage density was significantly increased, whereas neutrophil density was reduced, in DIO mice compared with lean mice. At 7 days of reperfusion, collagen deposition in the scar was significantly reduced and left ventricular (LV) dilation and cardiac hypertrophy were increased, indicative of adverse LV remodeling, in infarcted DIO mice. Characterization of a murine diet-induced model of obesity and insulin resistance that satisfies many aspects commonly observed in human obesity allows detailed examination of the adverse cardiovascular effects of diet-induced obesity at the molecular level.
流行病学研究表明,肥胖、胰岛素抵抗和糖尿病是缺血性心脏病患者的重要合并症,会增加心肌梗死后的死亡率和充血性心力衰竭的发生率。虽然ob/ob和db/db小鼠常用于研究伴有胰岛素抵抗或糖尿病的肥胖,但瘦素基因或其受体的突变在人类肥胖中很少见,相反,人类肥胖主要是饮食和生活方式因素导致的。因此,我们使用饮食诱导肥胖的小鼠模型来研究肥胖的生理影响以及饮食诱导肥胖(DIO)小鼠在心肌缺血再灌注损伤后的炎症和愈合反应。DIO小鼠出现高胰岛素血症、胰岛素抵抗和肝脂肪变性,心脏有明显的异位脂质沉积和心脏肥大,而血压无明显变化。再灌注24小时时趋化因子的mRNA水平以及再灌注24小时和72小时时细胞因子的mRNA水平,DIO小鼠均高于瘦小鼠。与瘦小鼠相比,再灌注72小时时,DIO小鼠肉芽组织中的巨噬细胞密度显著增加,而中性粒细胞密度降低。再灌注7天时,梗死的DIO小鼠瘢痕中的胶原沉积显著减少,左心室(LV)扩张和心脏肥大增加,表明左心室重构不良。一种满足人类肥胖中常见许多方面的饮食诱导肥胖和胰岛素抵抗小鼠模型的特征,使得能够在分子水平上详细研究饮食诱导肥胖对心血管的不良影响。